|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Estimating the world cancer burden: Globocan 2000. Int J Cancer.
94:153–156. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ogunbiyi JO: Hepatocellular carcinoma in
the developing world. Semin Oncol. 28:179–187. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cotter TG: Apoptosis and cancer: the
genesis of a research field. Nat Rev Cancer. 9:501–507. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi HH, Jong HS, Park JH, et al: A novel
ginseng saponin metabolite induces apoptosis and down-regulates
fibroblast growth factor receptor 3 in myeloma cells. Int J Oncol.
23:1087–1093. 2003.PubMed/NCBI
|
|
5
|
Hu C, Song G, Zhang B, Liu Z, Chen R,
Zhang H and Hu T: Intestinal metabolite compound K of panaxoside
inhibits the growth of gastric carcinoma by augmenting apoptosis
via Bid-mediated mitochondrial pathway. J Cell Mol Med. 16:96–106.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Attele AS, Wu JA and Yuan CS: Ginseng
pharmacology: multiple constituents and multiple actions. Biochem
Pharmacol. 58:1685–1693. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Joh EH, Lee IA, Jung IH and Kim DH:
Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1
activation - the key step of inflammation. Biochem Pharmacol.
82:278–286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kobashi K and Akao T: Relation of
intestinal bacteria to pharmacological effects of glycosides.
Bioscience Microflora. 16:1–7. 1997. View Article : Google Scholar
|
|
9
|
Wakabayashi C, Hasegawa H, Murata J and
Saiki I: The expression of in vivo antimetastatic effect of ginseng
protopanaxatriol saponins is mediated by their intestinal bacterial
metabolites after oral administration. J Traditional Med.
14:180–185. 1997.
|
|
10
|
Wakabayashi C, Hasegawa H, Murata J and
Saiki I: In vivo antimetastatic action of ginseng
protopanaxadiol saponins is based on their intestinal bacterial
metabolites after oral administration. Oncol Res. 9:411–417.
1997.
|
|
11
|
Akao T, Kanaoka M and Kobashi K:
Appearance of compound K, a major metabolite of ginsenoside Rb1 by
intestinal bacteria, in rat plasma after oral administration -
measurement of compound K by enzyme immunoassay. Biol Pharm Bull.
21:245–249. 1998. View Article : Google Scholar
|
|
12
|
Wang CZ, Kim KE, Du GJ, et al:
Ultra-performance liquid chromatography and time-of-flight mass
spectrometry analysis of ginsenoside metabolites in human plasma.
Am J Chin Med. 39:1161–1171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsutsumi YM, Tsutsumi R, Mawatari K,
Nakaya Y, Kinoshita M, Tanaka K and Oshita S: Compound K, a
metabolite of ginsenosides, induces cardiac protection mediated
nitric oxide via Akt/PI3K pathway. Life Sci. 88:725–729. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choo MK, Sakurai H, Kim DH and Saiki I: A
ginseng saponin metabolite suppresses tumor necrosis
factor-α-promoted metastasis by suppressing nuclear factor-κB
signaling in murine colon cancer cells. Oncol Rep. 19:595–600.
2008.PubMed/NCBI
|
|
15
|
Kim DY, Yuan HD, Chung IK and Chung SH:
Compound K, intestinal metabolite of ginsenoside, attenuates
hepatic lipid accumulation via AMPK activation in human hepatoma
cells. J Agric Food Chem. 57:1532–1537. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee BH, Lee SJ, Hur JH, Lee S, Sung JH,
Huh JD and Moon CK: In vitro antigenotoxic activity of novel
ginseng saponin metabolites formed by intestinal bacteria. Planta
Med. 64:500–503. 1998. View Article : Google Scholar
|
|
17
|
Lee SJ, Sung JH, Lee SJ, Moon CK and Lee
BH: Antitumor activity of a novel ginseng saponin metabolite in
human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer
Lett. 144:39–43. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hasegawa H, Sung JH, Matsumiya S, Uchiyama
M, Inouye Y, Kasai R and Yamasaki K: Reversal of daunomycin and
vinblastine resistance in multidrug-resistant P388 leukemia in
vitro through enhanced cytotoxicity by triterpenoids. Planta
Med. 61:409–413. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ming YL, Song G, Chen LH, et al:
Anti-proliferation and apoptosis induced by a novel intestinal
metabolite of ginseng saponin in human hepatocellular carcinoma
cells. Cell Biol Int. 31:1265–1273. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cossarizza A, Baccarani-Contri M,
Kalashnikova G and Franceschi C: A new method for the
cytofluorimetric analysis of mitochondrial membrane potential using
the J-aggregate forming lipophilic cation
5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine
iodide (JC-1). Biochem Biophys Res Commun. 197:40–45.
1993.PubMed/NCBI
|
|
21
|
Collins AR, Dobson VL, Dusinska M, Kennedy
G and Stetina R: The comet assay: what can it really tell us? Mutat
Res. 375:183–193. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Panayiotidis M, Tsolas O and Galaris D:
Glucose oxidase-produced H2O2 induces
Ca2+-dependent DNA damage in human peripheral blood
lymphocytes. Free Radic Biol Med. 26:548–556. 1999.
|
|
23
|
Hasegawa H: Proof of the mysterious
efficacy of ginseng: basic and clinical trials: metabolic
activation of ginsenoside: deglycosylation by intestinal bacteria
and esterification with fatty acid. J Pharmacol Sci. 95:153–157.
2004. View Article : Google Scholar
|
|
24
|
Lee JY, Shin JW, Chun KS, et al: Antitumor
promotional effects of a novel intestinal bacterial metabolite
(IH-901) derived from the protopanaxadiol-type ginsenosides in
mouse skin. Carcinogenesis. 26:359–367. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ming YL, Zheng ZZ, Chen LH and Tong QX:
Apoptosis induced by a novel intestinal metabolite of ginseng
saponin in human hepatocellular carcinoma BEL-7402 cells. Chin Trad
Herbal Drugs. 38:1511–1514. 2007.
|
|
26
|
Qi F, Li A, Inagaki Y, et al: Induction of
apoptosis by cinobufacini preparation through mitochondria- and
Fas-mediated caspase-dependent pathways in human hepatocellular
carcinoma cells. Food Chem Toxicol. 50:295–302. 2012. View Article : Google Scholar
|
|
27
|
Vaithinathan S, Saradha B and Mathur PP:
Methoxychlor induces apoptosis via mitochondria- and FasL-mediated
pathways in adult rat testis. Chem Biol Interact. 185:110–118.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nagata S: Fas ligand-induced apoptosis.
Annu Rev Genet. 33:29–55. 1999. View Article : Google Scholar
|
|
29
|
Schug ZT, Gonzalvez F, Houtkooper RH, Vaz
FM and Gottlieb E: BID is cleaved by caspase-8 within a native
complex on the mitochondrial membrane. Cell Death Differ.
18:538–548. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Medema JP, Scaffidi C, Kischkel FC,
Shevchenko A, Mann M, Krammer PH and Peter ME: FLICE is activated
by association with the CD95 death-inducing signaling complex
(DISC). EMBO J. 16:2794–2804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Herr I and Debatin KM: Cellular stress
response and apoptosis in cancer therapy. Blood. 98:2603–2614.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu X, Kim CN, Yang J, Jemmerson R and
Wang X: Induction of apoptotic program in cell-free extracts:
requirement for dATP and cytochrome c. Cell. 86:147–157. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Srinivasula SM, Ahmad M, Fernandes-Alnemri
T and Alnemri ES: Autoactivation of procaspase-9 by Apaf-1-mediated
oligomerization. Mol Cell. 1:949–957. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Slee EA, Harte MT, Kluck RM, et al:
Ordering the cytochrome c-initiated caspase cascade: hierarchical
activation of caspases-2, -3, -6, -7, -8, and -10 in a
caspase-9-dependent manner. J Cell Biol. 144:281–292. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jeong SJ, Dasgupta A, Jung KJ, Um JH,
Burke A, Park HU and Brady JN: PI3K/AKT inhibition induces
caspase-dependent apoptosis in HTLV-1-transformed cells. Virology.
370:264–272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Moon DO, Park SY, Choi YH, Kim ND, Lee C
and Kim GY: Melittin induces Bcl-2 and caspase-3-dependent
apoptosis through downregulation of Akt phosphorylation in human
leukemic U937 cells. Toxicon. 51:112–120. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Oh SH, Yin HQ and Lee BH: Role of the
Fas/Fas ligand death receptor pathway in ginseng saponin
metabolite-induced apoptosis in HepG2 cells. Arch Pharm Res.
27:402–406. 2004. View Article : Google Scholar : PubMed/NCBI
|
